Literature DB >> 8501998

Adherence to continuous screening for colorectal neoplasia.

R E Myers1, A M Balshem, T A Wolf, E A Ross, L Millner.   

Abstract

Continuous screening is defined as the periodic provision of an opportunity for diagnostic testing to a population of individuals who are asymptomatic and at increased risk for disease. If screening is offered periodically irrespective of response to an earlier screening invitation, this situation may be referred to as serial screening. When continuous screening is made available only to individuals who had tested previously, population member response is referred to as repeat screening. This study assessed adherence to serial- and repeat-colorectal cancer screening among older adult members of an independent practice association-type health maintenance organization (HMO) in two consecutive rounds of screening. In the first screening round, fecal occult blood tests (FOBTs) were sent to 1,565 subjects who were randomly assigned to receive usual care or behavioral interventions intended to encourage testing. Overall, 647 (41%) subjects completed and returned their tests. In the second screening round, FOBTs were mailed again to all subjects; however, the interventions were discontinued. Logistic regression analysis results shows that first-round testing was a significant independent predictor of serial adherence for subjects older than 65 years of age (odds ratio[OR] = 10.8) and those younger than 65 years of age (OR = 10.9); and a significant negative association between exposure to first-round intervention and serial adherence (OR = 0.5) was found among younger subjects. Among first-round adherers, age was significantly and positively related to repeat adherence (OR = 1.6). However, exposure to first-round intervention and having an abnormal FOBT result were significantly and negatively associated with repeat adherence (OR = 0.5 and OR = 0.4, respectively). The results of this study reported here indicate that previous screening is a strong predictor of serial adherence, and special efforts may be required to achieve high levels of serial and repeat adherence among younger adults. Additional research is needed to understand why persons with abnormal screening test results are unlikely to engage in repeat screening.

Entities:  

Mesh:

Year:  1993        PMID: 8501998     DOI: 10.1097/00005650-199306000-00004

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  19 in total

1.  Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.

Authors:  Y Niv; M Lev-El; G Fraser; G Abuksis; A Tamir
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Colorectal screening patterns and perceptions of risk among African-American users of a community health center.

Authors:  I M Lipkus; B K Rimer; P R Lyna; A A Pradhan; M Conaway; C T Woods-Powell
Journal:  J Community Health       Date:  1996-12

3.  Third Annual Fecal Occult Blood Testing in Community Health Clinics.

Authors:  Connie L Arnold; Alfred Rademaker; Michael S Wolf; Dachao Liu; Jill Hancock; Terry C Davis
Journal:  Am J Health Behav       Date:  2016-05

4.  Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.

Authors:  Caitlin C Murphy; Robert S Sandler; Hanna K Sanoff; Y Claire Yang; Jennifer L Lund; John A Baron
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-05       Impact factor: 11.382

5.  Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.

Authors:  Charlene L Stokamer; Craig T Tenner; Jhuma Chaudhuri; Eva Vazquez; Edmund J Bini
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

6.  Patient satisfaction with the colonoscopy procedure: endoscopists overestimate the importance of adverse physical symptoms.

Authors:  Maaike J Denters; Marije Deutekom; Bert Derkx; Patrick M Bossuyt; Paul Fockens; Evelien Dekker
Journal:  Frontline Gastroenterol       Date:  2012-05-06

7.  The effects of test preference, test access, and navigation on colorectal cancer screening.

Authors:  Constantine Daskalakis; Sally W Vernon; Randa Sifri; Melissa DiCarlo; James Cocroft; Jocelyn Andrel Sendecki; Ronald E Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-09       Impact factor: 4.254

8.  Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.

Authors:  Caitlin C Murphy; Sally W Vernon; Nicole M Haddock; Melissa L Anderson; Jessica Chubak; Beverly B Green
Journal:  Prev Med       Date:  2014-06-15       Impact factor: 4.018

9.  Colorectal cancer screening: what do women from diverse ethnic groups want?

Authors:  Judith M E Walsh; Sue E Kim; George Sawaya; Celia P Kaplan; Sabrina T Wong; Steve E Gregorich; Eliseo J Pérez-Stable
Journal:  J Gen Intern Med       Date:  2012-09-12       Impact factor: 5.128

10.  Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.

Authors:  Paul Ritvo; Ronald Myers; M Elisabeth Del Giudice; Lawrence Pazsat; Michelle Cotterchio; Roberta Howlett; Verna Mai; Patrick Brown; Terrence Sullivan; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.